Genomic Landscape Impacts Induction Outcome with CPX-351 in Patients with Acute Myeloid Leukemia
Chetasi Talati(Moffitt Cancer Center), Kendra Sweet(Moffitt Cancer Center), Gail J. Roboz(Cornell University), Hugo F. Fernández(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), David A. Sallman(Moffitt Cancer Center), Jeffrey E. Lancet(Cornell University), Eric Padron(Moffitt Cancer Center), Andrew Kuykendall(Moffitt Cancer Center), Martin S. Tallman(Memorial Sloan Kettering Cancer Center), Aaron D. Goldberg(Memorial Sloan Kettering Cancer Center), Alan F. List(TE Laboratories (Ireland)), Yehuda E. Deutsch(Moffitt Cancer Center), Onyee Chan(Moffitt Cancer Center), Christopher Famulare(Memorial Sloan Kettering Cancer Center), Pinkal Desai(NewYork–Presbyterian Hospital), Rami S. Komrokji(Moffitt Cancer Center)
Cited by 6
Related Papers
Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel
|Blood|2016|5.9k
Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN
|Blood|2022|3.1k